Marc Hertz, CEO of @gri_bio, opens his Virtual Investor Summer Spotlight On Demand Conference segment with 2 truths and a lie before sharing what drives his work in inflammatory, fibrotic, and autoimmune diseases. Watch here: vimeo.com/1103221494/273… $GRI

Tim Lu, CEO of @sentibio, shares how Senti Bio is pioneering smarter medicines to outsmart complex disease during his feature in the Virtual Investor Summer Spotlight On Demand Conference. Listen to his story here: vimeo.com/1103222002/acd… $SNTI

Wally Klemp, CEO of Moleculin Biotech, joins the Virtual Investor Summer Spotlight On Demand Conference to spotlight Moleculin’s progress in targeting hard-to-treat cancers and viral diseases. Watch now: vimeo.com/1103249130/fa3… $MBRX

The Summer Spotlight is now LIVE! bit.ly/4lJL3jk $MBRX $CNSP $GRI $AMIX $SNTI $NUWE $AKTX $PALI $NVNO $OTLK Moleculin Biotech CNS Pharma @gri_bio @autonomixmed @sentibio @nuwellis_inc @akaritx @palisadebio @envvenomedical @outlooktx @itolerance_inc @kaidabio @exxelpharm

#InCaseYouMissedIt: The Virtual Investor Summer Spotlight On-Demand Conference is now available to stream anytime. 👉 Replay here: bit.ly/4lJL3jk #SummerSpotlight #VirtualInvestor #StayConnected

WhatThisMeans – Key Data Building Efforts – Listen to Abizer Gaslightwala, President and CEO of Akari Therapeutics, discuss continued key research efforts on its Novel Antibody Drug Conjugate Payload PH1. bit.ly/4ffL5NB $AKTX

WhatThisMeans – Interim Data – Dr. Marc Hertz, President, Chief Executive Officer and Director of GRI Bio, Inc., discusses the Company’s recently released 6-Week Interim Biomarker Data in ongoing Phase 2a study in Idiopathic Pulmonary Fibrosis (“IPF”). bit.ly/44UJbOK $GRI

enVVeno Medical participated in Virtual Investor’s What This Means segment to discuss the rising awareness of CVI following President Trump’s diagnosis and the potential impact of enVVeno. Access the segment to learn more: vimeo.com/1107075148/728… $NVNO enVVeno Medical President Donald J. Trump

Sonnet participated in a What This Means segment, where CMO Dr. Richard Kenney discussed the expansion of its SB221 trial in platinum-resistant ovarian cancer and plans to evaluate higher doses ahead of Phase 2a next year. Watch here: vimeo.com/1108857330?sha… $SONN @sonnetbio

Senti joined Virtual Investor where Dr. Rajangam, President and Head of R&D, shared what this means for the recommended Phase 2 dose of SENTI-202, its potential first-in-class CAR-NK therapy for AML and other blood cancers. vimeo.com/1109325415/9f2… $SNTI Senti Biosciences

Exciting news! Our companies are presenting at the Webull Corporate Connect Biotech/MedTech Webinar Series taking place August 19 to 21, 2025. Lineup: Tue, Aug 19 – $AKTX, $SNTI, $CNSP Wed, Aug 20 – $MBRX, $GRI, $AIM Thu, Aug 21 – $NVNO, $AMIX, $NUWE 🔗: bit.ly/3Hvo9NL

JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025 bit.ly/45rgoAc @webullglobal

Check out our latest KOL Connect with @palisadebio and Dr. Brian Feagan, who discusses FSCD, the unmet need and how PALI-2108’s localized approach could change the treatment landscape. 🔗 Watch here: vimeo.com/1112415075/bb7… $PALI #FibrostenoticCrohnsDisease #UlcerativeColitis

📅 Save the Date! $AKTX will participate in a #VirtualInvestor Closing Bell segment on September 4th at 4 PM ET. Don't miss it— register here: bit.ly/3HUDJ5S #Oncology #ADCs #AntibodyDrugConjugates @investorvirtual

Don’t Miss This! 🚨 #TuneInTomorrow at 4 PM ET for a live corporate update and Q&A from @akaritx in a #VirtualInvestor Closing Bell segment. Get the latest insights and have your questions answered in real time. Register now: bit.ly/3HUDJ5S $AKTX #Oncology #ADCs

Dr. Robert Schwartz, Autonomix CMO, discusses the recently announced results from the post hoc analysis of Autonomix's PoC 1 human clinical trial in a new Virtual Investor Co. “What This Means” segment. Watch it here: bit.ly/42Vr0q2 $AMIX

Autonomix joined a What This Means segment, where CMO Dr. Robert Schwartz highlighted PoC1 results showing sustained pain reduction, improved quality of life, and 100% zero opioid use. Watch here: vimeo.com/1115786041/191… $AMIX @autonomixmed

📢 Tune in today! Akari Therapeutics will be live on the Virtual Investor platform at 4:00 PM ET, sharing a corporate update and hosting a Q&A during their Closing Bell segment. Don’t miss this opportunity! Register here: bit.ly/3HUDJ5S $AKTX @akaritx

⏰ Don’t miss it — we’re going live! Akari Therapeutics joins a #VirtualInvestor Closing Bell at 4:00 PM ET with a corporate update and Q&A. Join us to hear the latest developments and have your questions answered live. 🔗 Register now: bit.ly/3HUDJ5S $AKTX @akaritx

Nuwellis participated in a What This Means, where Ryan Marthaler, VP of Product Marketing & BD, discussed the ~$3M NIH grant to accelerate Vivian™, the pediatric CRRT device. Learn more: vimeo.com/1119231149/b46… Nuwellis $NUWE #FluidManagement #Ultrafiltration #NIHGrant